Skip to main content

Table 7 Carry-over, treatment, and period effects after adjusting for each other

From: Prevention of Morbidity in Sickle Cell Disease (POMS2a)—overnight auto-adjusting continuous positive airway pressure compared with nocturnal oxygen therapy: a randomised crossover pilot study examining patient preference and safety in adults and children

Type

Carry-over

Treatment

Period

Multiple imputation

0.981 (−0.523, 2.48)

0.143 (−0.116, 0.401)

− 0.257 (− 0.520, 0.00658)

Best case

0.518 (− 1.78, 2.81)

−0.0227 (− 0.609, 0.563)

0.523 (− 0.0635, 1.109)

Worst case

−0.400 (−4.49, 3.69)

0.318 (− 0.850, 1.49)

−1.32 (−2.49, − 0.150)

  1. Values are shown with confidence intervals
  2. Auto-adjusting continuous positive airway pressure (APAP) was set as the reference treatment